US Stock MarketDetailed Quotes

BCYC Bicycle Therapeutics

Watchlist

13.810
-6.300-31.33%

Close Dec 13 16:00 ET

13.700
-0.110-0.80%

Post 16:07 ET

953.53MMarket Cap-4.21P/E (TTM)

Bicycle Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-3,786.05%-39.83M

-230.89%-44.63M

-52.70%-70.87M

29.59%-60.63M

-56.02%-47.29M

82.54%-1.03M

244.90%34.1M

-75.80%-46.41M

-482.07%-86.11M

-190.46%-30.31M

Net income from continuing operations

-1.81%-50.8M

6.55%-39.81M

32.00%-26.56M

-60.28%-180.66M

-63.78%-49.1M

-76.03%-49.9M

-58.80%-42.6M

-41.72%-39.06M

-68.69%-112.72M

-66.20%-29.98M

Depreciation and amortization

28.52%2.17M

-0.30%1.64M

6.49%1.66M

77.45%6.55M

19.34%1.65M

33.70%1.69M

166.61%1.65M

268.96%1.56M

161.82%3.69M

240.54%1.39M

Deferred tax

-145.59%-3.32M

93.02%-110K

63.58%-767K

166.44%3.31M

87.93%-282K

810.06%7.27M

-81.68%-1.58M

-181.55%-2.11M

-198.32%-4.98M

---2.34M

Other non cash items

1,038.46%1.04M

11.46%107K

1.96%104K

136.20%1.04M

809.64%755K

3.41%91K

-29.41%96K

-24.44%102K

-5.56%442K

-31.40%83K

Change In working capital

-97.16%921K

-123.00%-15.72M

-242.38%-54.58M

11,308.18%76.66M

-62.43%-8.13M

93.03%32.39M

3,122.64%68.34M

-80.28%-15.94M

-98.31%672K

-187.13%-5M

-Change in receivables

84.88%-8.3M

-111.80%-7.54M

-254.16%-15.27M

89.41%-1.2M

31.93%-5.88M

-507.14%-54.88M

543.13%63.87M

-141.78%-4.31M

-523.91%-11.35M

-106.26%-8.63M

-Change in prepaid assets

188.99%3.54M

-135.82%-393K

-383.57%-8.39M

-2.57%-2.07M

2,073.50%2.54M

-1,515.30%-3.98M

201.86%1.1M

-29.38%-1.74M

32.08%-2.02M

105.19%117K

-Change in payables and accrued expense

462.69%8.34M

-90.01%1.36M

-120.91%-11.34M

-30.31%10.4M

-89.30%481K

-74.78%1.48M

89.97%13.57M

-97.96%-5.13M

526.75%14.92M

70.86%4.5M

-Change in other current assets

7.25%1.14M

5.45%1.1M

7.53%1.09M

55.15%4.19M

56.66%1.07M

58.04%1.06M

50.79%1.05M

55.23%1.01M

567.82%2.7M

-79.81%683K

-Change in other current liabilities

-21.02%-1.19M

-64.96%-1.13M

-28.15%-1.12M

-148.96%-3.6M

-110.54%-1.06M

-101.84%-985K

-29.17%-682K

-1,297.26%-874K

-1,229.69%-1.45M

79.68%-503K

-Change in other working capital

-102.90%-2.6M

13.63%-9.12M

-299.08%-19.56M

3,329.56%68.95M

-353.43%-5.29M

3,049.42%89.69M

-278.22%-10.55M

-27.27%-4.9M

-105.75%-2.14M

-113.49%-1.17M

Cash from discontinued investing activities

Operating cash flow

-3,786.05%-39.83M

-230.89%-44.63M

-52.70%-70.87M

29.59%-60.63M

-56.02%-47.29M

82.54%-1.03M

244.90%34.1M

-75.80%-46.41M

-482.07%-86.11M

-190.46%-30.31M

Investing cash flow

Cash flow from continuing investing activities

13.35%-435K

-51.62%-420K

99.43%-12K

84.57%-2.93M

96.48%-51K

83.18%-502K

97.17%-277K

55.87%-2.1M

-835.32%-18.99M

-35.71%-1.45M

Net PPE purchase and sale

13.35%-435K

-51.62%-420K

99.43%-12K

84.57%-2.93M

96.48%-51K

83.18%-502K

97.17%-277K

55.87%-2.1M

-835.32%-18.99M

-35.71%-1.45M

Cash from discontinued investing activities

Investing cash flow

13.35%-435K

-51.62%-420K

99.43%-12K

84.57%-2.93M

96.48%-51K

83.18%-502K

97.17%-277K

55.87%-2.1M

-835.32%-18.99M

-35.71%-1.45M

Financing cash flow

Cash flow from continuing financing activities

-113.61%-31.93M

4,371.25%549.61M

-31.16%1.87M

3,636.21%250.03M

-93.44%386K

147,466.67%234.63M

6,203.59%12.29M

504.00%2.72M

-97.91%6.69M

-96.91%5.89M

Net issuance payments of debt

----

--0

----

--0

----

Net common stock issuance

-100.42%-979K

4,394.98%545.11M

--0

4,272.17%249.35M

--10K

--234.49M

--12.13M

--2.72M

-98.09%5.7M

----

Proceeds from stock option exercised by employees

556.12%912K

2,627.27%4.5M

93,450.00%1.87M

-31.04%682K

103.24%376K

-12.58%139K

-15.38%165K

-99.56%2K

-86.23%989K

-91.87%185K

Cash from discontinued financing activities

Financing cash flow

-113.61%-31.93M

4,371.25%549.61M

-31.16%1.87M

3,636.21%250.03M

-93.44%386K

147,466.67%234.63M

6,203.59%12.29M

504.00%2.72M

-97.91%6.69M

-96.91%5.89M

Net cash flow

Beginning cash position

182.56%961.91M

55.73%457.54M

55.38%526.97M

-22.69%339.15M

58.42%572.63M

-8.67%340.43M

-27.88%293.82M

-22.69%339.15M

222.58%438.68M

39.28%361.47M

Current changes in cash

-130.97%-72.2M

994.23%504.56M

-50.70%-69.01M

289.49%186.47M

-81.50%-46.95M

2,780.59%233.1M

239.16%46.11M

-49.13%-45.79M

-132.38%-98.41M

-114.44%-25.87M

Effect of exchange rate changes

287.71%1.7M

-137.87%-192K

-191.83%-416K

220.18%1.35M

-63.73%1.29M

65.32%-903K

134.56%507K

175.12%453K

7.51%-1.12M

59,333.33%3.55M

End cash Position

55.67%891.41M

182.56%961.91M

55.73%457.54M

55.38%526.97M

58.42%572.63M

-8.67%340.43M

-27.88%293.82M

-22.69%339.15M

Free cash flow

-2,537.00%-40.27M

-233.20%-45.05M

-46.12%-70.88M

39.53%-63.56M

-49.07%-47.34M

82.76%-1.53M

201.47%33.82M

-55.70%-48.51M

-524.69%-105.1M

-176.10%-31.76M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-3,786.05%-39.83M	-230.89%-44.63M	-52.70%-70.87M	29.59%-60.63M	-56.02%-47.29M	82.54%-1.03M	244.90%34.1M	-75.80%-46.41M	-482.07%-86.11M	-190.46%-30.31M
Net income from continuing operations	-1.81%-50.8M	6.55%-39.81M	32.00%-26.56M	-60.28%-180.66M	-63.78%-49.1M	-76.03%-49.9M	-58.80%-42.6M	-41.72%-39.06M	-68.69%-112.72M	-66.20%-29.98M
Depreciation and amortization	28.52%2.17M	-0.30%1.64M	6.49%1.66M	77.45%6.55M	19.34%1.65M	33.70%1.69M	166.61%1.65M	268.96%1.56M	161.82%3.69M	240.54%1.39M
Deferred tax	-145.59%-3.32M	93.02%-110K	63.58%-767K	166.44%3.31M	87.93%-282K	810.06%7.27M	-81.68%-1.58M	-181.55%-2.11M	-198.32%-4.98M	---2.34M
Other non cash items	1,038.46%1.04M	11.46%107K	1.96%104K	136.20%1.04M	809.64%755K	3.41%91K	-29.41%96K	-24.44%102K	-5.56%442K	-31.40%83K
Change In working capital	-97.16%921K	-123.00%-15.72M	-242.38%-54.58M	11,308.18%76.66M	-62.43%-8.13M	93.03%32.39M	3,122.64%68.34M	-80.28%-15.94M	-98.31%672K	-187.13%-5M
-Change in receivables	84.88%-8.3M	-111.80%-7.54M	-254.16%-15.27M	89.41%-1.2M	31.93%-5.88M	-507.14%-54.88M	543.13%63.87M	-141.78%-4.31M	-523.91%-11.35M	-106.26%-8.63M
-Change in prepaid assets	188.99%3.54M	-135.82%-393K	-383.57%-8.39M	-2.57%-2.07M	2,073.50%2.54M	-1,515.30%-3.98M	201.86%1.1M	-29.38%-1.74M	32.08%-2.02M	105.19%117K
-Change in payables and accrued expense	462.69%8.34M	-90.01%1.36M	-120.91%-11.34M	-30.31%10.4M	-89.30%481K	-74.78%1.48M	89.97%13.57M	-97.96%-5.13M	526.75%14.92M	70.86%4.5M
-Change in other current assets	7.25%1.14M	5.45%1.1M	7.53%1.09M	55.15%4.19M	56.66%1.07M	58.04%1.06M	50.79%1.05M	55.23%1.01M	567.82%2.7M	-79.81%683K
-Change in other current liabilities	-21.02%-1.19M	-64.96%-1.13M	-28.15%-1.12M	-148.96%-3.6M	-110.54%-1.06M	-101.84%-985K	-29.17%-682K	-1,297.26%-874K	-1,229.69%-1.45M	79.68%-503K
-Change in other working capital	-102.90%-2.6M	13.63%-9.12M	-299.08%-19.56M	3,329.56%68.95M	-353.43%-5.29M	3,049.42%89.69M	-278.22%-10.55M	-27.27%-4.9M	-105.75%-2.14M	-113.49%-1.17M
Cash from discontinued investing activities
Operating cash flow	-3,786.05%-39.83M	-230.89%-44.63M	-52.70%-70.87M	29.59%-60.63M	-56.02%-47.29M	82.54%-1.03M	244.90%34.1M	-75.80%-46.41M	-482.07%-86.11M	-190.46%-30.31M
Investing cash flow
Cash flow from continuing investing activities	13.35%-435K	-51.62%-420K	99.43%-12K	84.57%-2.93M	96.48%-51K	83.18%-502K	97.17%-277K	55.87%-2.1M	-835.32%-18.99M	-35.71%-1.45M
Net PPE purchase and sale	13.35%-435K	-51.62%-420K	99.43%-12K	84.57%-2.93M	96.48%-51K	83.18%-502K	97.17%-277K	55.87%-2.1M	-835.32%-18.99M	-35.71%-1.45M
Cash from discontinued investing activities
Investing cash flow	13.35%-435K	-51.62%-420K	99.43%-12K	84.57%-2.93M	96.48%-51K	83.18%-502K	97.17%-277K	55.87%-2.1M	-835.32%-18.99M	-35.71%-1.45M
Financing cash flow
Cash flow from continuing financing activities	-113.61%-31.93M	4,371.25%549.61M	-31.16%1.87M	3,636.21%250.03M	-93.44%386K	147,466.67%234.63M	6,203.59%12.29M	504.00%2.72M	-97.91%6.69M	-96.91%5.89M
Net issuance payments of debt	----	----	----	--0	--0	----	----	----	--0	----
Net common stock issuance	-100.42%-979K	4,394.98%545.11M	--0	4,272.17%249.35M	--10K	--234.49M	--12.13M	--2.72M	-98.09%5.7M	----
Proceeds from stock option exercised by employees	556.12%912K	2,627.27%4.5M	93,450.00%1.87M	-31.04%682K	103.24%376K	-12.58%139K	-15.38%165K	-99.56%2K	-86.23%989K	-91.87%185K
Cash from discontinued financing activities
Financing cash flow	-113.61%-31.93M	4,371.25%549.61M	-31.16%1.87M	3,636.21%250.03M	-93.44%386K	147,466.67%234.63M	6,203.59%12.29M	504.00%2.72M	-97.91%6.69M	-96.91%5.89M
Net cash flow
Beginning cash position	182.56%961.91M	55.73%457.54M	55.38%526.97M	-22.69%339.15M	58.42%572.63M	-8.67%340.43M	-27.88%293.82M	-22.69%339.15M	222.58%438.68M	39.28%361.47M
Current changes in cash	-130.97%-72.2M	994.23%504.56M	-50.70%-69.01M	289.49%186.47M	-81.50%-46.95M	2,780.59%233.1M	239.16%46.11M	-49.13%-45.79M	-132.38%-98.41M	-114.44%-25.87M
Effect of exchange rate changes	287.71%1.7M	-137.87%-192K	-191.83%-416K	220.18%1.35M	-63.73%1.29M	65.32%-903K	134.56%507K	175.12%453K	7.51%-1.12M	59,333.33%3.55M
End cash Position	55.67%891.41M	182.56%961.91M	55.73%457.54M	55.38%526.97M	55.38%526.97M	58.42%572.63M	-8.67%340.43M	-27.88%293.82M	-22.69%339.15M	-22.69%339.15M
Free cash flow	-2,537.00%-40.27M	-233.20%-45.05M	-46.12%-70.88M	39.53%-63.56M	-49.07%-47.34M	82.76%-1.53M	201.47%33.82M	-55.70%-48.51M	-524.69%-105.1M	-176.10%-31.76M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--

Heat List

Overall

No Data